SCHEMBL23905500

SCHEMBL23905500

Bc1cc(OC)n2nc(C(=O)OC)c(C(=O)OC)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.34
▸ MAPT P10636 3/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.33
▸ ELANE P08246 4/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ GAA P10253 2/20 0.33
▸ HPGD P15428 3/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ F2 P00734 2/20 0.32
▸ PLAU P00749 2/20 0.32
▸ ATM Q13315 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905478 0.83 ELANE (0.38) EGFRKDM4EMAPTNPSR1ELANE
SCHEMBL1663399 0.71 ELANE (0.40) EGFRKDM4EMAPTNPSR1ELANE
SCHEMBL29277951 0.70 KDM4E (0.39) EGFRKDM4EMAPTNPSR1ELANE
SCHEMBL31309441 0.69 KDM4C (0.40) KDM4EMAPTNPSR1ALDH1A1GAA
SCHEMBL3686647 0.69 EGFR (0.40) EGFRKDM4EMAPTNPSR1ELANE
SCHEMBL1662907 0.69 ALDH1A1 (0.48) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL1664597 0.68 ALDH1A1 (0.43) EGFRKDM4EMAPTALDH1A1GAA
SCHEMBL1663371 0.67 EGFR (0.43) EGFRKDM4EMAPTNPSR1ALDH1A1
SCHEMBL1662993 0.67 ALDH1A1 (0.47) EGFRKDM4EMAPTELANEALDH1A1
SCHEMBL1663705 0.66 SPR (0.34) EGFRKDM4EMAPTNPSR1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 — — WO disclosed
Send feedback